ZEB1 and liver cancer: In conclusion, ZEB1 is a key regulator of transcriptional plasticity in liver cancer, allowing the cells to adapt to challenges from environmental and therapeutic pressures through the activation of EMT, stemness and chemoresistance programs, which contribute to the aggressivity of the tumors and poorer prognosis of liver cancer patients.